These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Matched-Pair Comparison of Rauscher I; Krönke M; König M; Gafita A; Maurer T; Horn T; Schiller K; Weber W; Eiber M J Nucl Med; 2020 Jan; 61(1):51-57. PubMed ID: 31253741 [No Abstract] [Full Text] [Related]
8. False-Positive Uptake in Splenic Hemangioma on 68Ga-PSMA PET/CT Scan for Late Biochemical Recurrence of Prostate Cancer. Brazão ÉS; Ribeiro AMB; Lima ENP; da Costa WH; Zequi SC Clin Nucl Med; 2022 Jan; 47(1):e14-e16. PubMed ID: 34034314 [TBL] [Abstract][Full Text] [Related]
9. Advantage of 68Ga-PSMA PET/CT on Postradiotherapy Response Assessment of Juvenile Nasal Angiofibroma. Sakthivel P; Thakar A; Thankarajan Arunraj S; Bhalla AS; Kumar R Clin Nucl Med; 2021 Feb; 46(2):e123-e124. PubMed ID: 33156054 [TBL] [Abstract][Full Text] [Related]
10. 68Ga-PSMA-11 PET/CT for prostate cancer staging and risk stratification in Chinese patients. Zang S; Shao G; Cui C; Li TN; Huang Y; Yao X; Fan Q; Chen Z; Du J; Jia R; Sun H; Hua Z; Tang J; Wang F Oncotarget; 2017 Feb; 8(7):12247-12258. PubMed ID: 28103574 [TBL] [Abstract][Full Text] [Related]
11. 68Ga-PSMA Uptake in Brain Metastasis of Gastric Carcinoma. Kesim S; Oksuzoglu K Clin Nucl Med; 2022 Sep; 47(9):e585-e586. PubMed ID: 35930713 [TBL] [Abstract][Full Text] [Related]
12. More advantages in detecting bone and soft tissue metastases from prostate cancer using Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003 [TBL] [Abstract][Full Text] [Related]
13. The meta-analysis of the effect of 68Ga-PSMA-PET/CT diagnosis of prostatic cancer compared with bone scan. Zhao R; Li Y; Nie L; Qin K; Zhang H; Shi H Medicine (Baltimore); 2021 Apr; 100(15):e25417. PubMed ID: 33847640 [TBL] [Abstract][Full Text] [Related]